Mirum Pharmaceuticals

MIRM | NASDAQ | 0 Sledující

$44.46

1.05%

$0.46

Sledovat

Overview Metrics Financials

Breakdown	12/31/2024 USD	12/31/2023 USD	12/31/2022 USD	12/31/2021 USD
Total revenue	336,888 +80.76%	186,374 +141.85%	77,062 +302.66%	19,138 -
Cost of revenue	81,643 +73.56%	47,039 +280.14%	12,374 +550.24%	1,903 -
Gross profit	255,245 +83.19%	139,335 +115.40%	64,688 +275.33%	17,235 -
Operating expense	342,851 +37.97%	248,489 +26.84%	195,908 +2.76%	190,648 -
Operating income	-87,606 +19.74%	-109,154 +16.82%	-131,220 +24.33%	-173,413 -
Pretax Income	-86,912 +46.49%	-162,424 -14.33%	-142,071 -69.23%	-83,951 -
Tax Provision	1,030 +3.94%	991 +115.47%	-6,406 -17,413.51%	37 -
Net income	-87,942 +46.18%	-163,415 -20.45%	-135,665 -61.53%	-83,988 -
EPS	-1.85 +53.75%	-4 +0.25%	-4.01 -44.77%	-2.77 -
Diluted EPS	-1.85 +53.75%	-4 +0.25%	-4.01 -44.77%	-2.77 -
Average Shares	47,523 +16.23%	40,885 +20.82%	33,839 +11.60%	30,322 -
Diluted Average Shares	47,523 +16.23%	40,885 +20.82%	33,839 +11.60%	30,322 -
EBIT	-72,601 +50.72%	-147,319 -16.83%	-126,092 -90.01%	-66,361 -
EBITDA	-48,972 +64.12%	-136,490 -11.50%	-122,411 -87.21%	-65,386 -

Soubory cookie používáme ke zlepšení prohlížení na webu.